tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
Company AnnouncementsJacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
3d ago
1167
Jacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline
PremiumCompany Announcements
Jacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline
22d ago
1167
Jacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials
PremiumCompany Announcements
Jacobio’s KRAS G12C and SHP2 Therapy Shows Promising Results in Clinical Trials
23d ago
1167
Jacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy
PremiumCompany Announcements
Jacobio Pharmaceuticals Appoints Dr. Andrea Wang-Gillam as Co-CEO to Boost Global Strategy
1M ago
1167
Jacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors
PremiumCompany Announcements
Jacobio Pharmaceuticals Launches Promising Study on JAB-23E73 for KRAS-Altered Tumors
2M ago
1167
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study
PremiumCompany AnnouncementsJacobio Pharmaceuticals Advances Cancer Treatment with JAB-23E73 Study
2M ago
1167
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
Premium
Company Announcements
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
2M ago
1167
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
Premium
Company Announcements
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
2M ago
1167
Jacobio Pharmaceuticals Advances Strategic Focus with Capital Increase and Equity Transfer
PremiumCompany Announcements
Jacobio Pharmaceuticals Advances Strategic Focus with Capital Increase and Equity Transfer
2M ago
1167
Jacobio Pharmaceuticals Announces Shareholding Changes and Share Repurchase Updates
PremiumCompany Announcements
Jacobio Pharmaceuticals Announces Shareholding Changes and Share Repurchase Updates
3M ago
1167
Jacobio Pharmaceuticals Sees Increase in Concert Party Shareholdings
PremiumCompany Announcements
Jacobio Pharmaceuticals Sees Increase in Concert Party Shareholdings
4M ago
1167
Jacobio Pharmaceuticals Reports Significant Progress in Oncology Pipeline for H1 2025
PremiumCompany Announcements
Jacobio Pharmaceuticals Reports Significant Progress in Oncology Pipeline for H1 2025
4M ago
1167
Jacobio Pharmaceuticals Establishes Nomination Committee to Enhance Governance
PremiumCompany AnnouncementsJacobio Pharmaceuticals Establishes Nomination Committee to Enhance Governance
4M ago
1167
Jacobio Pharmaceuticals Announces Board Meeting for Interim Results
Premium
Company Announcements
Jacobio Pharmaceuticals Announces Board Meeting for Interim Results
4M ago
1167
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
Premium
Company Announcements
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
5M ago
1167
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
PremiumCompany Announcements
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
5M ago
1167
Jacobio Pharmaceuticals Sees Increased Shareholdings by Concert Parties
PremiumCompany Announcements
Jacobio Pharmaceuticals Sees Increased Shareholdings by Concert Parties
5M ago
1167
Jacobio Pharmaceuticals Announces Share Repurchase Plan to Boost Shareholder Value
PremiumCompany Announcements
Jacobio Pharmaceuticals Announces Share Repurchase Plan to Boost Shareholder Value
5M ago
1167
Jacobio Advances Pan-KRAS Inhibitor JAB-23E73 in Clinical Trials
PremiumCompany Announcements
Jacobio Advances Pan-KRAS Inhibitor JAB-23E73 in Clinical Trials
6M ago
1167
Jacobio Pharmaceuticals Announces AGM Results with Key Resolutions Passed
PremiumCompany AnnouncementsJacobio Pharmaceuticals Announces AGM Results with Key Resolutions Passed
7M ago
1167
Jacobio’s KRAS G12C Inhibitor Glecirasib Gains Approval for Market Launch
Premium
Company Announcements
Jacobio’s KRAS G12C Inhibitor Glecirasib Gains Approval for Market Launch
7M ago
1167
Jacobio Pharmaceuticals Announces 2025 AGM and Key Resolutions
Premium
Company Announcements
Jacobio Pharmaceuticals Announces 2025 AGM and Key Resolutions
7M ago
1167

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >